⌘K

Home/Filings/4/0001144204-15-012337

4//SEC Filing

ENDOCYTE INC 4

Accession 0001144204-15-012337

CIK 0001235007operating

View on SEC.gov Company Profile

Filed

Feb 25, 7:00 PM ET

Accepted

Feb 26, 6:30 PM ET

Size

6.7 KB

Accession

0001144204-15-012337

Insider Transaction Report

Form 4

Period: 2015-02-06

ENDOCYTE INCECYT

DirectorPresident and CEO

Transactions

Exercise/Conversion
Common Stock
2015-02-06$5.21/sh+52,356$272,775→ 305,196 total
Exercise/Conversion
Stock Option (right to buy)
2015-02-06+52,356→ 0 total
Exercise: $5.21Exp: 2017-05-31→ Common Stock (52,356 underlying)

Footnotes (1)

[F1]The option is fully vested and immediately exercisable.

Documents

1 file

4
v403027_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

ENDOCYTE INC

CIK 0001235007

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001235007

Filing Metadata

Form type: 4
Filed: Feb 25, 7:00 PM ET
Accepted: Feb 26, 6:30 PM ET
Size: 6.7 KB

View on SEC.gov